Cell Expansion Market Analysis 2019 to 2027 - Reuters

 

Cell Expansion Market Analysis 2019 to 2027

Cell Expansion Market Analysis 2019 to 2027 | Growing With CAGR of 15.0% | Credence Research

Wed Jul 3, 2019 - 10:30am UTC

In 2018, the global cell expansion market was estimated at US$ 9,743.7 million and is expected to reach US$ 33,443.2 million by 2027, expanding at a CAGR of 15.0 % between 2019 and 2027.

SANJOSE, United States – July 3, 2019

The latest market report published by Credence Research, Inc. “Global Cell Expansion Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global cell expansion market was valued at US$ 9,743.7 Mn in 2018, and is expected to reach US$ 33,443.2 Mn by 2027, expanding at a CAGR of 15.0% from 2019 to 2027.

Market Insights

World Health Organization (WHO), supports the fact that 70% of the global mortality rate is associated with high prevalence rate of chronic diseases in both developed and developing nations. Lack of effective treatment regimen has resulted in increasing demand for regenerative medicine, stem cell therapy and personalized medicine which ensures maximum therapeutic efficacy and safety with minimal side effects. On the contrary high cost associated with cell expansion operations and dearth of skilled workforce will possibly dampen the cell expansion market growth during the forecast period.

Browse the full report Cell Expansion Market – Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/cell-expansion-market

Consumables are reigning the product segment for cell expansion market. The major factor responsible for its positive market growth is significant rise in high throughput screening which increases the consumption of consumables during the investigation of new drug stage. Disposables will be registering rapid growth during the forecast period on account of negligible risk associated with cross contamination of laboratory equipments and flourishing biotechnology and pharmaceutical industry.

Regenerative medicine is spearheading the application segment for cell expansion market. In the last 2 decades there has been technological advancement in the translational research pertaining to molecular biology and tissue engineering used in regenerative medicine. It ensures the restoration of normal cellular activity of internal organs present in the human body. Clinical diagnostics are gathering the attention of researchers worldwide owing to the technological advancement in companion diagnostic kits and increasing public health awareness resulting in early screening of chronic ailments.

North America with a market share of 35.2% is dominating the regional segment for cell expansion market. The chief contributing factors propelling the cell expansion market growth in the region are rising prevalence of chronic disease and increasing demand for regenerative medicine. As per the research citing of National Health Council of CDC, approximately 133 million Americans are suffering with chronic ailments. Europe is accountable for 30.5% market share primarily due to presence of major players such as Merck Millipore, GE Healthcare, Becton Dickinson & Company etc. Asia Pacific presently holds 17.5% market share on account of developing healthcare infrastructure and supportive regulatory environment provided by the local healthcare agencies in the region.

Medical device companies spearheading the cell expansion market are Becton Dickinson & Company, Beckman Coulter, Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Miltenyi Biotec, STEMCELL Technologies, Terumo Biotec and Thermo Fisher Scientific.

Key Market Movements:
The rising incidence rate of chronic illness worldwide
Increasing demand for regenerative medicine and stem cell therapy owing to its safety and efficacy
The supportive regulatory environment provided by healthcare agencies worldwide

For Customization and Other Inquiry: https://www.credenceresearch.com/inquiry-before-buying/59748

ToC:
Chapter 1. Preface
………

Chapter 2. Executive Summary
………..

Chapter 3. Cell Expansion Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global Cell Expansion Market, by Key Players, 2018

Chapter 4. Global Cell Expansion Market, by Product
4.1. Overview
4.2. Instrument
4.3. Consumables
4.4. Disposables

Chapter 5. Global Cell Expansion Market, by Application
5.1. Overview
5.2. Regenerative Medicine
5.3. Cancer & Stem Cell Research
5.4. Clinical Diagnostics
5.5. Others

Chapter 6. Global Cell Expansion Market, by Geography
………….

Chapter 7. Company Profiles
7.1. Becton Dickinson & Company
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Beckman Coulter, Inc.
7.3. Corning Incorporation
7.4. Danaher Corporation
7.5. GE Healthcare
7.6. Merck Millipore
7.7. Miltenyi Biotec
7.8. STEMCELL Technologies
7.9. Terumo BCT
7.10. Thermo Fisher Scientific
……………toc continued

Get Sample: https://www.credenceresearch.com/sample-request/59748

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/cell-expansion-market

This content is not produced by Reuters Editorial News. It is produced by VC NewsNetwork. For content enquiry, please reach us at

Latest News >

Digital streaming service Iflix secures new funding

The final size of the funding was undisclosed, but the total is well over US$50M.

08:43am UTC

Fixanar enters partnership with Cathay Financial, Indovina to finance Vietnam’s SME

Fixanar Vietnam, Indovina Bank, and Cathay Financial Holdings on July 18 announced a partnership to improve access to financing for SMEs in Vietnam.

04:05am UTC

Arbor Ventures to co-lead US$15 million Series A in US Data Residency Compliance Firm InCountry

This funding round highlights the importance of global data protection in businesses and an overwhelming market demand triggered by the growing challenges of companies in expansion.

03:46am UTC

Corporate travel startup receives US$3M pre-Series A funding

The Singaporean startup is one of its kind in the Southeast Asian leisure-oriented travel industry.

08:22am UTC

Singapore’s AI Intelligence Platform secures US$100 million to offer new data suites

Near plans to use the funding capital to launch a new suite of data products and expand into strategic markets including Australia and the US.

08:11am UTC